As previously released on May 28th, 2022, Windsor Regional Hospital is monitoring an international shortage of a solution known as iodinated contrast dye used in diagnostic imaging scans that will result in the postponement of non-emergency CT, cardiac angiograms and diagnostic studies requiring contrast dye until at least the end of June.

WRH was alerted to the shortage by Health Canada on Friday, May 26 and along with all other hospitals in Ontario ordered to restrict use of contrast dye to emergency CT scans. The hospital uses a product supplied by GE Healthcare, a major global supplier of the dye. GE has four global manufacturing sites, one of which, located in China, was recently forced to shut down due to COVID-19 concerns. The plant has reopened at 60% capacity but it is expected to take several weeks before production is restored to full capacity.

The latest update from our supplier has informed us that expected shipments are delayed until the end of June. As a result, we are anticipating having to postpone non-emergency appointments.

WRH will continue to prioritize CT scans and cardiac angiograms for emergency situations including patients with major trauma, possible strokes and cardiac issues, bowel blockages and critical care patients.

The hospital will be contacting patients whose upcoming CT scan and procedural appointments are impacted by the rationing of contrast dye use. WRH is working with the West Region of Ontario Health and provincial bodies to prioritize the use of contrast dye.

WRH will provide further updates in the coming days about the anticipated impact on diagnostic scan volumes. WRH will work with patients and referring practitioners about potential diagnostic alternatives depending on their medical concern.